Brett S. Spector

Director/Board Member at Fesariustherapeutics, Inc.

Finance

Health Technology

Profile

Brett S.
Spector is currently a Director at Fesariustherapeutics, Inc. He was previously the President at SuttonBrook Capital Management LP from 2009 to 2012.

Brett S. Spector active positions

Companies	Position	Start
Fesariustherapeutics, Inc. Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021.	Director/Board Member	-

All active positions of Brett S. Spector

Former positions of Brett S. Spector

Companies	Position	End
SuttonBrook Capital Management LP SuttonBrook Capital Management LP Investment ManagersFinance Founded in 2002, SuttonBrook Capital Management LLC is a hedge fund manager located in New York City.	Director of Finance/CFO	2012-03-31

See the detail of Brett S. Spector's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brett S. Spector's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
SuttonBrook Capital Management LP SuttonBrook Capital Management LP Investment ManagersFinance Founded in 2002, SuttonBrook Capital Management LLC is a hedge fund manager located in New York City.	Finance
Fesariustherapeutics, Inc. Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021.	Health Technology